Ito et al. identified in 2010 cereblon (CRBN), which is the substrate adaptor of the CRBN-CRL4 E3 ubiquitin ligase, as the primary target of all IMiDs responsible for the teratogenicity as well as the anti-cancer effects [95]. This evidence concerns the gene IL17RB and cancer.